Bottom line
ERHSX vs QAAGZX: the short answer
ERHSX (Eaton Vance Worldwide Health Sciences Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds.
But QAAGZX is far broader, holding 277 positions to 42 for ERHSX, so beyond the top names it adds exposure ERHSX doesn't have.
QAAGZX is cheaper at 0.86% vs 1.43% — a difference of $57 a year per $10,000 invested.
Over five years, ERHSX returned +6.2% a year vs +4.1% for QAAGZX (reporting dates differ).
Updated Nov 19, 2026
ERHSX vs QAAGZX side by side
| ERHSX | QAAGZX | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Morgan Stanley | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.43% | 0.86% |
| Annual cost per $10k | $143 | $86 |
| 10-yr cost on $10k (prospectus) | $1,744 | $1,061 |
| Max front load | 0% | None |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +3.2% | +18.1% |
| 5-yr return (annualized) | +6.2% | +4.1% |
| 10-yr return (annualized) | +6.7% | +9.0% |
| Best quarter | — | +23.4% |
| Worst quarter | — | −15.8% |
| Net assets (fund) | $757.9M | $751.7M |
| Number of holdings | 42 | 277 |
| Portfolio turnover | 3% | 65% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
12 of ERHSX's top 25 holdings also appear in QAAGZX's top 25.
| Holding | ERHSX | QAAGZX |
|---|---|---|
| Eli Lilly & Co | 12.47% | 14.06% |
| AbbVie Inc | 6.46% | 5.12% |
| Johnson & Johnson | 6.45% | 6.64% |
| UnitedHealth Group Inc | 5.49% | 5.88% |
| Merck & Co Inc | 5.08% | 4.00% |
| Bristol-Myers Squibb Co | 4.25% | 2.12% |
| Vertex Pharmaceuticals Inc | 3.38% | 2.26% |
| Gilead Sciences Inc | 3.34% | 2.79% |
| Thermo Fisher Scientific Inc | 2.79% | 2.53% |
| Intuitive Surgical Inc | 2.72% | 1.89% |
| Stryker Corp | 2.21% | 1.78% |
| Abbott Laboratories | 1.65% | 1.91% |
Source: SEC Form N-PORT
ERHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
QAAGZX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
FAQ
What is the difference between ERHSX and QAAGZX?
Which is cheaper, ERHSX or QAAGZX?
Should I own both ERHSX and QAAGZX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.